Literature DB >> 11938501

Causes of death after total hip arthroplasty: a nationwide cohort study with 24,638 patients.

Pekka Paavolainen1, Eero Pukkala, Pekka Pulkkinen, Tuomo Visuri.   

Abstract

Based on the nationwide registration of the total hip arthroplasties (THAs) in Finland since 1980, a cohort of 24,638 patients with primary THA was gathered and followed for causes of death until December 31, 1996. The causes of death were divided into 20 main categories according to the classification of diseases ICD-10. The number of person-years was 153,410, and the mean length of follow-up of a person was 6.2 years. During the follow-up, 4,626 patients died; the expected number was 6,746. The standardized mortality ratio (SMR) was 0.69 (95% confidence interval; 0.67-0.70), without any difference between men and women. The total risk increased during the follow-up, with the highest being 0.84 (95% confidence interval, 0.81-0.87). Among the ICD categories, there were significantly low SMRs for cancers (0.54), accidents (0.74), cardiovascular diseases (0.70), and respiratory diseases (0.46). Among the diseases, there was a constant and significant decline of the SMR for dementia and Alzheimer's disease (0.50), diabetes (0.40), myocardial infarction (0.73), hypertension (0.68), other ischemic diseases (0.70), other heart diseases (0.57), and cerebrovascular diseases (0.70). The explanation for the decreased SMRs seems to be attributed to factors other than the THA per se, such as preoperative patient selection, more active lifestyle after THA, and possibly the use of anti-inflammatory drugs.

Entities:  

Mesh:

Year:  2002        PMID: 11938501     DOI: 10.1054/arth.2002.30774

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  13 in total

1.  Cause-Specific Mortality Trends Following Total Hip and Knee Arthroplasty.

Authors:  Clement J Michet; Cathy D Schleck; Dirk R Larson; Hilal Maradit Kremers; Daniel J Berry; David G Lewallen
Journal:  J Arthroplasty       Date:  2016-10-20       Impact factor: 4.757

2.  Mortality After Total Knee and Total Hip Arthroplasty in a Large Integrated Health Care System.

Authors:  Maria C S Inacio; Mark T Dillon; Alex Miric; Ronald A Navarro; Elizabeth W Paxton
Journal:  Perm J       Date:  2017

3.  Outcomes of shoulder arthroplasty in diabetic patients as assessed by peri-operative A1C.

Authors:  Joseph M Statz; Eric R Wagner; John W Sperling; Robert H Cofield
Journal:  Int Orthop       Date:  2018-03-18       Impact factor: 3.075

4.  A retrospective comparative study of mortality and causes of death among patients with metal-on-metal and metal-on-polyethylene total hip prostheses in primary osteoarthritis after a long-term follow-up.

Authors:  Tuomo Visuri; Håkan Borg; Pekka Pulkkinen; Pekka Paavolainen; Eero Pukkala
Journal:  BMC Musculoskelet Disord       Date:  2010-04-23       Impact factor: 2.362

5.  Long-Term Mortality Trends After Total Hip and Knee Arthroplasties: A Population-Based Study.

Authors:  Hilal Maradit Kremers; Dirk R Larson; Mohamed Noureldin; Cathy D Schleck; William A Jiranek; Daniel J Berry
Journal:  J Arthroplasty       Date:  2015-12-17       Impact factor: 4.757

6.  Early mortality after modern total hip arthroplasty.

Authors:  Michael Aynardi; Luis Pulido; Javad Parvizi; Peter F Sharkey; Richard H Rothman
Journal:  Clin Orthop Relat Res       Date:  2008-10-10       Impact factor: 4.176

7.  VKORC1 variant genotypes influence warfarin response in patients undergoing total joint arthroplasty: a pilot study.

Authors:  Alejandro González Della Valle; Saurabh Khakharia; Charles J Glueck; Nicole Taveras; Ping Wang; Robert N Fontaine; Eduardo A Salvati
Journal:  Clin Orthop Relat Res       Date:  2008-11-26       Impact factor: 4.176

8.  Long-term Mortality After Revision THA.

Authors:  Jie J Yao; Hilal Maradit Kremers; Matthew P Abdel; Dirk R Larson; Jeanine E Ransom; Daniel J Berry; David G Lewallen
Journal:  Clin Orthop Relat Res       Date:  2018-02       Impact factor: 4.176

9.  The effect of co-morbidities on health-related quality of life in patients placed on the waiting list for total joint replacement.

Authors:  Ulla Tuominen; Marja Blom; Johanna Hirvonen; Seppo Seitsalo; Matti Lehto; Pekka Paavolainen; Kalevi Hietanieni; Pekka Rissanen; Harri Sintonen
Journal:  Health Qual Life Outcomes       Date:  2007-03-15       Impact factor: 3.186

10.  Mortality after total hip replacement surgery: A systematic review.

Authors:  J R Berstock; A D Beswick; E Lenguerrand; M R Whitehouse; A W Blom
Journal:  Bone Joint Res       Date:  2014-06       Impact factor: 5.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.